Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07285707 · ClinicalTrials.gov registry record · NA
Acupuncture and Chinese Herbal Medicine for Long COVID
A NA study of Long COVID, sponsored by Southern California University of Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07285707 is a NA study of Long COVID that is actively recruiting participants, run by Southern California University of Health Sciences. The registered enrollment target is 10 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07285707, a NA study of Long COVID, is actively recruiting participants, sponsored by Southern California University of Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
List of the Hypothesis: Primary hypothesis: A flexible acupuncture and Chinese herbal medicine protocol will be feasible, acceptable, and useful for the treatment of long COVID. Secondary hypothesis: Long COVID patients receiving acupuncture treatment or acupuncture treatment and Chinese herbal supplements over an 8-week period will see improvements in their symptoms, function, and quality of life measurements. Specific Aims of This Research (Purpose of the study): To study the feasibility, acceptability and utility of an acupuncture and Chinese herbal supplement treatment protocol for patients with long COVID and preliminarily assess the effects of treatment. Currently Available Research on This Subject: Studies indicate that acupuncture can effectively treat symptoms that are similar to those often seen in long COVID patients. Additionally, recent studies and clinical evidence suggest that there is substantial potential for acupuncture in the treatment of long COVID. Acupuncture may be beneficial because it can address many symptoms simultaneously with a single intervention, whereas symptom clusters can be difficult to manage with pharmaceuticals due to the need for multiple pharmaceutical agents. Summary of the research protocol/methodology: Five patients will receive acupuncture treatment, and five patients will receive acupuncture and Chinese herbal medicine. Each participant will receive 16 acupuncture treatments over the course of eight weeks (i.e., twice per week). Each treatment session will last for 30 minutes. Follow-up will occur at 12 weeks (i.e., four weeks after the final treatment session). Significance of this research to the health and welfare of general public: There is currently not a single, specific treatment for long COVID. If acupuncture treatment alone and/or acupuncture and Chinese herbal medicine combined are feasible, acceptable, and efficacious in the improvement of long COVID symptoms, it will offer patients additional treatme
Conditions Studied
Interventions
- PROCEDURE Acupuncture
Study Locations (1)
California
- SCUHS - Whittier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07285707
The ClinicalTrials.gov registry entry for NCT07285707 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (100% lower). The listed sponsor is Southern California University of Health Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.
NCT07285707 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07285707 about?
NCT07285707 is a clinical study titled "Acupuncture and Chinese Herbal Medicine for Long COVID". List of the Hypothesis: Primary hypothesis: A flexible acupuncture and Chinese herbal medicine protocol will be feasible, acceptable, and useful for the treatment of long COVID. Secondary hypothesis: Long COVID patients receiving acupuncture treatment or acupuncture treatment and Chinese herbal su...
What is the current status of trial NCT07285707?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-09-10. Estimated completion is 2026-12-31.
What conditions does trial NCT07285707 study?
This clinical trial studies the following conditions: Long COVID.
What interventions are being tested in trial NCT07285707?
The interventions under investigation include: Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT07285707?
This trial is sponsored by Southern California University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07285707 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Water-based Activity to Enhance Recovery in Long COVID-19
RECRUITING · NA
-
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Sauna for Long Covid
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.